Repro-Med Systems, Inc. (OQ:KRMD)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 24 Carpenter Rd
CHESTER NY 10918-1057
Tel: N/A
Website: www.repro-med.com
IR: See website
<
Key People
R. John Fletcher
Chairman of the Board
Donald B. Pettigrew
President, Chief Executive Officer
Karen Fisher
Chief Financial Officer, Treasurer
Manuel A Marques
Chief Operating Officer
   
Business Overview
REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company's products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator. The FREEDOM60 consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. The HIgH-Flo is designed for self-administration of medicine under the skin. The RES-Q-VAC is a hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC pump to various sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The On-Line Calculator is a tool to help determine which of the Company's Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Needle Sets are to be used based on the medication being administered and time of infusion.
Financial Overview
For the nine months ended 30 September 2019, Repro-Med Systems, Inc. revenues increased 29% to $16.9M. Net income decreased 49% to $645K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Selling, general and administrative increase of 41% to $8.6M (expense), Research and development increase from $161K to $450K (expense).
Employees: 63 as of Feb 28, 2014
Reporting Currency: U.S. Dollars
Enterprise value: $181.32M as of Sep 30, 2019
Annual revenue (TTM): $21.21M as of Sep 30, 2019
EBITDA (TTM): $1.51M as of Sep 30, 2019
Net annual income (TTM): $0.29M as of Sep 30, 2019
Free cash flow (TTM): -$0.88M as of Sep 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 39,501,870 as of Nov 6, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization